P1 variant antithrombins Glasgow (393 Arg to His) and Pescara (393 Arg to Pro) have increased heparin affinity and are resistant to catalytic cleavage by elastase Implications for the heparin activation mechanism
- 25 March 1991
- journal article
- Published by Wiley in FEBS Letters
- Vol. 280 (2) , 216-220
- https://doi.org/10.1016/0014-5793(91)80296-f
Abstract
The heparin affinity of normal and two P1 variants of antithrombin-III (AT) was studied by gradient elution with NaCl in Tris buffer on heparin-Sepharose. At pH 7.4 normal AT eluted art [Na+] 0.78 mol/l and the variants both showed increased affinity with AT Pescara eluting at [Na+] 0.86 mol/l and AT Glasgow at [Na+] 0.92 mol/l. We have earlier proposed a model for heparin activation in which the native state of AT maintains a salt bridge involving the P1 Arg-393 residue. Binding of heparin induces a higher heparin affinity conformation in which the salt bridge is disrupted to reveal the reactive centre for inhibition of thrombin. The Glasgow and Pescara variants, lacking a reactive centre P1 basic residue, would be unable to form this salt bridge, and we suggested that the high affinity conformation which they adopt as their native state would resemble the heparin induced conformation. To examine this model, we measured the heparin induced fluorescence of two P1 variants and tested the susceptibility of their reactive loops to catalytic cleavage. Both variants had fluorescence spectra indistinguishable from normal AT. In the absence of heparin, neither variant was more susceptible than normal to catalytic cleavage by human neutrophil elastase. These findings suggest that the conformation of these P1 variants is different to that of fully heparinized normal ATKeywords
This publication has 9 references indexed in Scilit:
- A novel amino acid substitution in the reactive site of a congenital variant antithrombinPublished by Elsevier ,1989
- Binding of Heparin to Human Antithrombin III Activates Selective Chemical Modification at Lysine 236Published by Elsevier ,1989
- Antithrombin Glasgow, 393 arg to his: A P1 reactive site variant with increased heparin affinity but no thrombin inhibitory activityFEBS Letters, 1988
- Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser.Journal of Clinical Investigation, 1988
- Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to HisBlood, 1987
- Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparinBritish Journal of Haematology, 1987
- Plakalbumin, α1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosisNature, 1985
- Electroimmuno AssayScandinavian Journal of Clinical and Laboratory Investigation, 1972
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970